These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 31569687)

  • 1. Nanoparticles Targeting STATs in Cancer Therapy.
    Ashrafizadeh M; Ahmadi Z; Kotla NG; Afshar EG; Samarghandian S; Mandegary A; Pardakhty A; Mohammadinejad R; Sethi G
    Cells; 2019 Sep; 8(10):. PubMed ID: 31569687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
    Groner B; von Manstein V
    Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the interleukin-6/Jak/stat pathway in human malignancies.
    Sansone P; Bromberg J
    J Clin Oncol; 2012 Mar; 30(9):1005-14. PubMed ID: 22355058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
    Lai SY; Johnson FM
    Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential and controversy of targeting STAT family members in cancer.
    Verhoeven Y; Tilborghs S; Jacobs J; De Waele J; Quatannens D; Deben C; Prenen H; Pauwels P; Trinh XB; Wouters A; Smits ELJ; Lardon F; van Dam PA
    Semin Cancer Biol; 2020 Feb; 60():41-56. PubMed ID: 31605750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT activation in malignancies: roles in tumor progression and in the generation of antineoplastic effects of IFNs.
    Wang BX; Platanias LC; Fish EN
    J Interferon Cytokine Res; 2013 Apr; 33(4):181-8. PubMed ID: 23570384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.
    Heppler LN; Frank DA
    Trends Cancer; 2017 Dec; 3(12):816-827. PubMed ID: 29198438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT inhibitors for cancer therapy.
    Furqan M; Akinleye A; Mukhi N; Mittal V; Chen Y; Liu D
    J Hematol Oncol; 2013 Dec; 6():90. PubMed ID: 24308725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT-mediated EGFR signaling in cancer.
    Quesnelle KM; Boehm AL; Grandis JR
    J Cell Biochem; 2007 Oct; 102(2):311-9. PubMed ID: 17661350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [STAT proteins in cancerogenesis and therapy of malignancies].
    Konjević G
    Srp Arh Celok Lek; 2009; 137(1-2):98-105. PubMed ID: 19370975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the STAT pathway in head and neck cancer: recent advances and future prospects.
    Nikitakis NG; Siavash H; Sauk JJ
    Curr Cancer Drug Targets; 2004 Dec; 4(8):637-51. PubMed ID: 15578920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting silibinin in the antiproliferative pathway.
    Li L; Zeng J; Gao Y; He D
    Expert Opin Investig Drugs; 2010 Feb; 19(2):243-55. PubMed ID: 20047507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting transcription factor STAT3 for cancer prevention and therapy.
    Chai EZ; Shanmugam MK; Arfuso F; Dharmarajan A; Wang C; Kumar AP; Samy RP; Lim LH; Wang L; Goh BC; Ahn KS; Hui KM; Sethi G
    Pharmacol Ther; 2016 Jun; 162():86-97. PubMed ID: 26478441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review.
    Ashrafizadeh M; Rafiei H; Mohammadinejad R; Afshar EG; Farkhondeh T; Samarghandian S
    Phytother Res; 2020 Aug; 34(8):1745-1760. PubMed ID: 32157749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Patents on Nanoparticles and Nanoformulations for Cancer Therapy.
    Ray A; Mandal A; Joseph M; Mitra AK
    Recent Pat Drug Deliv Formul; 2016; 10(1):11-23. PubMed ID: 26282464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1.
    Xu J; Wu Z; Huang J
    Drug Des Devel Ther; 2021; 15():1705-1716. PubMed ID: 33935493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of STATs in transcriptional control and their impact on cellular function.
    Bromberg J; Darnell JE
    Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.